Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale | 2025-03-31 | 13G | Anika Therapeutics, Inc. ANIK | BlackRock Inc. BLK | 963,078 6.800% | -594,804 (-38.18%) | Filing History |
| 2025-02-05 5:28 pm Sale | 2024-12-31 | 13G | Anika Therapeutics, Inc. ANIK | BlackRock Inc. BLK | 1,557,882 10.600% | -206,725 (-11.72%) | Filing History |
| 2025-01-23 3:55 pm Sale | 2024-12-31 | 13G | Anika Therapeutics, Inc. ANIK | Dimensional Fund Advisors LP | 657,355 4.500% | -164,097 (-19.98%) | Filing History |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Anika Therapeutics, Inc. ANIK | BlackRock Inc. BLK | 1,764,607 11.900% | 0 (Unchanged) | Filing History |
| 2024-10-23 5:04 pm Purchase | 2024-09-30 | 13G | Anika Therapeutics, Inc. ANIK | BlackRock Inc. BLK | 1,764,607 11.900% | 203,495 (+13.04%) | Filing History |
| 2024-05-30 4:31 pm Purchase | 2024-05-28 | 13D | Anika Therapeutics, Inc. ANIK | Caligan Partners LP | 1,435,993 9.700% | 12,500 (+0.88%) | Filing History |
| 2024-04-05 12:21 pm Purchase | 2024-03-31 | 13G | Anika Therapeutics, Inc. ANIK | BlackRock Inc. BLK | 1,561,112 10.700% | 177,235 (+12.81%) | Filing History |
| 2024-03-06 7:30 pm Purchase | 2024-03-04 | 13D | Anika Therapeutics, Inc. ANIK | Caligan Partners LP | 1,423,493 9.700% | 342,133 (+31.64%) | Filing History |
| 2024-02-13 4:58 pm Sale | 2023-12-29 | 13G | Anika Therapeutics, Inc. ANIK | VANGUARD GROUP INC | 764,045 5.220% | -219,723 (-22.33%) | Filing History |
| 2024-02-09 11:09 am Purchase | 2023-12-31 | 13G | Anika Therapeutics, Inc. ANIK | Trigran Investments, Inc. | 2,139,054 14.600% | 574,513 (+36.72%) | Filing History |
| 2024-02-09 09:59 am Sale | 2024-02-14 | 13G | Anika Therapeutics, Inc. ANIK | Dimensional Fund Advisors LP | 821,452 5.600% | -138,294 (-14.41%) | Filing History |
| 2024-01-24 2:27 pm Sale | 2023-12-31 | 13G | Anika Therapeutics, Inc. ANIK | BlackRock Inc. BLK | 1,383,877 9.500% | -32,258 (-2.28%) | Filing History |
| 2024-01-22 10:52 am Sale | 2023-12-31 | 13G | Anika Therapeutics, Inc. ANIK | STATE STREET CORP STT | 309,041 2.110% | -599,826 (-66.00%) | Filing History |
| 2023-10-06 2:34 pm Sale | 2023-09-30 | 13G | Anika Therapeutics, Inc. ANIK | BlackRock Inc. BLK | 1,416,135 9.700% | -1,110,667 (-43.96%) | Filing History |
| 2023-09-11 06:01 am Purchase | 2023-09-08 | 13D | Anika Therapeutics, Inc. ANIK | Caligan Partners LP | 1,081,360 7.400% | 179,274 (+19.87%) | Filing History |
| 2023-08-17 08:00 am Purchase | 2023-08-09 | 13D | Anika Therapeutics, Inc. ANIK | Caligan Partners LP | 902,086 6.200% | 902,086 (New Position) | Filing History |
| 2023-02-14 10:33 am Sale | 2022-12-31 | 13G | Anika Therapeutics, Inc. ANIK | AMERIPRISE FINANCIAL INC AMP | 181,943 1.250% | -805,790 (-81.58%) | Filing History |
| 2023-02-10 2:42 pm Purchase | 2023-02-14 | 13G | Anika Therapeutics, Inc. ANIK | Dimensional Fund Advisors LP | 959,746 6.600% | 103,622 (+12.10%) | Filing History |
| 2023-02-10 1:24 pm Purchase | 2022-12-31 | 13G | Anika Therapeutics, Inc. ANIK | Trigran Investments, Inc. | 1,564,541 10.700% | 71,296 (+4.77%) | Filing History |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Anika Therapeutics, Inc. ANIK | VANGUARD GROUP INC | 983,768 6.730% | 17,855 (+1.85%) | Filing History |